Alzheimer’s disease — which affects an estimated 7 million Americans — is notoriously difficult to detect, especially in its ...

Opens in a new tab or window A biomarker test identified tau pathology in Alzheimer's disease before fibrillary tangles developed. Neurofibrillary tangle formation can be prevented by targeting ...

It is a well-known fact that Alzheimer's disease is a neurological condition that is characterized by the loss of neurons and ...

A new biomarker test can detect early-stage tau protein clumping up to a decade before it appears on brain scans, improving ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Detecting toxic forms of tau before they weave into dense thickets of tangles could pave the way for earlier diagnosis and treatment of tauopathies, including Alzheimer’s disease. In the February 10 ...

The rapid influx of new medications brought to market over the past decade has revolutionized health care by offering new ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer’s disease. Nature Medicine , 2025; DOI: 10.1038/s41591-024-03400-0 Cite This Page : ...

This news may put some minds at ease. “Our test identifies very early stages of tau tangle formation — up to a decade before any tau clumps can show up on a brain scan,” said senior study ...

Years before neurofibrillary tangles (NFTs) of tau protein show up in brain scans of patients with Alzheimer’s disease (AD), a biomarker test developed at the University of Pittsburgh School of ...

More information: Phospho-tau serine-262 and serine-356 as biomarkers of pre-tangle soluble tau assemblies in Alzheimer's disease, Nature Medicine (2025). DOI: 10.1038/s41591-024-03400-0 Journal ...